Drug Shortage Report for TWYNSTA

Last updated on 2018-11-01 History
Report ID 57591
Drug Identification Number 02371022
Brand name TWYNSTA
Common or Proper name TWYNSTA 40 + 5 MG
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status MARKETED
Active Ingredient(s) AMLODIPINE TELMISARTAN
Strength(s) 5MG 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28s
ATC code C09DB
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-09-24
Actual start date 2018-09-19
Estimated end date 2018-10-29
Actual end date 2018-10-31
Shortage status Resolved
Updated date 2018-11-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-11-01 English Compare
v10 2018-10-31 English Compare
v9 2018-10-31 French Compare
v8 2018-10-31 English Compare
v7 2018-10-03 French Compare
v6 2018-10-03 English Compare
v5 2018-09-20 English Compare
v4 2018-09-19 French Compare
v3 2018-09-19 English Compare
v2 2018-08-07 French Compare
v1 2018-08-07 English Compare

Showing 1 to 11 of 11